CY1116843T1 - HUMAN MONOCLONE ANTIBODIES TO CONNECTOR 1 PROGRAMMED DEATH (PD-L1) - Google Patents
HUMAN MONOCLONE ANTIBODIES TO CONNECTOR 1 PROGRAMMED DEATH (PD-L1)Info
- Publication number
- CY1116843T1 CY1116843T1 CY20151100952T CY151100952T CY1116843T1 CY 1116843 T1 CY1116843 T1 CY 1116843T1 CY 20151100952 T CY20151100952 T CY 20151100952T CY 151100952 T CY151100952 T CY 151100952T CY 1116843 T1 CY1116843 T1 CY 1116843T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antibodies
- methods
- connector
- human
- programmed death
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Η παρούσα αποκάλυψη παρέχει απομονωθέντα μονοκλωνικά αντισώματα, ιδιαιτέρως ανθρώπινα μονοκλωνικά αντισώματα που ειδικώς συνδέονται προς PD-L1 με υψηλή συνάφεια. Επίσης παρέχονται μόρια νουκλεϊνικού οξέος που κωδικοποιούν τα αντισώματα αυτής της αποκάλυψης, φορείς έκφρασης, κύτταρα ξενιστές και μέθοδοι για έκφραση των αντισωμάτων της παρούσας περιγραφής. Επίσης παρέχονται ανοσοπροϊόντα σύζευξης, διπλά-ειδικά μόρια και φαρμακευτικές συνθέσεις που περιλαμβάνουν τα αντισώματα της εφεύρεσης. Η αποκάλυψη επίσης παρέχει μεθόδους για ανίχνευση PD-L1, καθώς επίσης μεθόδους για θεραπεία διαφόρων ασθενειών, που συμπεριλαμβάνουν καρκίνο και μολυσματώδεις ασθένειες, χρησιμοποιώντας αντι-PD-L1 αντισώματα.The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to PD-L1 with high affinity. Also provided are nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells, and methods for expressing the antibodies herein. Also provided are immunoconjugates, double-specific molecules, and pharmaceutical compositions comprising the antibodies of the invention. The disclosure also provides methods for detecting PD-L1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PD-L1 antibodies.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69642605A | 2005-07-01 | 2005-07-01 | |
EP06786260.7A EP1907424B1 (en) | 2005-07-01 | 2006-06-30 | Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1116843T1 true CY1116843T1 (en) | 2017-03-15 |
Family
ID=58459811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100952T CY1116843T1 (en) | 2005-07-01 | 2015-10-26 | HUMAN MONOCLONE ANTIBODIES TO CONNECTOR 1 PROGRAMMED DEATH (PD-L1) |
Country Status (1)
Country | Link |
---|---|
CY (1) | CY1116843T1 (en) |
-
2015
- 2015-10-26 CY CY20151100952T patent/CY1116843T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121648T1 (en) | HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH l(PD-1) AND METHODS OF TREATING CANCER USING ANTI-PD-1 ANTIBODIES ALONE OR IN COMBINATION WITH OTHER IMMUNOTHERAPEUTICS | |
SG163554A1 (en) | Human monoclonal antibodies to programmed death ligand 1 (pd-l1) | |
CY1117236T1 (en) | MONOCLONIC ANTIBODIES AGAINST GLYPICAN-3 | |
CY1123609T1 (en) | OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF | |
CY1118949T1 (en) | HUMAN ANTIBODIES BINDING CXCR4 AND THEIR USES | |
CY1113089T1 (en) | Human Monoclonal Antibodies to Specific Protective Membrane Antigen (PSMA) | |
EA200970477A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO BTLA AND METHODS OF APPLICATION | |
NO20082559L (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
EA200870021A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO FUKOZIL-GM1 AND METHODS OF APPLICATION OF ANTI-FUKOSIL-GM1 ANTIBODIES | |
CY1119454T1 (en) | ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA | |
CY1119539T1 (en) | FULLY HUMAN ANTIBILES SPECIAL FOR CADM1 | |
EA200800953A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO CD70 | |
NO20083053L (en) | Human monoclonal antibodies to O8E | |
MX2022009306A (en) | Cd28 single domain antibodies and multivalent and multispecific constructs thereof. | |
CY1116458T1 (en) | HUMAN ANTI-CD38 ANTIBODIES AND USES ABOUT THESE | |
CY1116582T1 (en) | HUMAN ANTIBODIES Binding to Lymphocyte Activation Gene-3 (LEG-3), AND USES THEREOF | |
MX2010005830A (en) | Anti-b7h4 monoclonal antibody-drug conjugate and methods of use. | |
TR201910348T4 (en) | Antibodies to matrix metalloproteinase 9. | |
MY150246A (en) | Alpha 5 - beta 1 antibodies and their uses | |
DE602005027399D1 (en) | FOR HUMAN MATRIPTASE SPECIFIC TIE PROTEINS | |
EA201101516A1 (en) | ANTIBODIES SPECIFIC FOR KADGERINA-17 | |
CY1116843T1 (en) | HUMAN MONOCLONE ANTIBODIES TO CONNECTOR 1 PROGRAMMED DEATH (PD-L1) | |
CY1114151T1 (en) | HUMAN monoclonal antibodies for the movement of Tyrosine Protein 7 (RTK7) and their use | |
CY1113958T1 (en) | HUMAN MONOCLONIC ANTIBODIES IN FUKOZYL-GM1 AND METHODS FOR USE ANTI-FUKOZYL-GM1 | |
CY1114506T1 (en) | MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN programmed death (PD-1) AND METHODS OF TREATMENT AGAINST CANCER USING ANTI-PD-1 INDIVIDUALLY OR IN COMBINATION WITH OTHER AGENTS ANOSOTHERAPEFTIKOUS |